Bank of New York Mellon Corp
BankPosition in SUPN — Supernus Pharmaceuticals, Inc.
CIK 1390777
NEW YORK, NY
Position in SUPN
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$17,552,961
-$1,179,903 QoQ
Shares Held
377,402
+4.1% QoQ
Ownership
0.649%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#34
of 335 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 90%
Shared 0%
None 10%
Common Shares in SUPN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Bank of New York Mellon Corp holds $1,289,702,180 across 44 Drug Manufacturers - Specialty & Generic names. SUPN ranks #14 (1.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
3,322,319 | $238,741,833 | |
| 2 | VTRS |
Viatris Inc
|
14,288,053 | $226,894,274 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
294,413 | $159,521,790 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
699,125 | $117,830,519 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
3,411,532 | $83,957,795 | |
| 6 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,899,912 | $64,369,013 | |
| 7 | ALKS |
Alkermes plc.
|
1,097,282 | $57,497,573 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
441,831 | $49,016,724 |
All Filings in SUPN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $17,552,961 | 377,402 | Shares | Defined | 2026-08-06 | |
| 2026-03-31 | $18,732,864 | 362,408 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $18,428,159 | 370,788 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $17,997,757 | 376,601 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $12,525,351 | 397,378 | Shares | Defined | 2025-08-05 | |
| 2025-03-31 | $12,625,154 | 385,501 | Shares | Defined | 2025-04-29 | |
| 2024-12-31 | $14,448,955 | 399,584 | Shares | Defined | 2025-02-04 | |
| 2024-09-30 | $11,612,988 | 372,450 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $11,379,099 | 425,387 | Shares | Defined | 2024-07-25 | |
| 2024-03-31 | $14,427,161 | 422,960 | Shares | Defined | 2024-04-25 | |
| 2023-12-31 | $12,889,062 | 445,372 | Shares | Defined | 2024-01-29 | |
| 2023-09-30 | $12,569,904 | 455,927 | Shares | Defined | 2023-10-24 | |
| 2023-06-30 | $13,768,079 | 458,020 | Shares | Defined | 2023-08-03 | |
| 2023-03-31 | $17,685,128 | 488,135 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $18,228,258 | 511,025 | Shares | Other | 2023-02-14 | |
| 2022-09-30 | $17,643,532 | 521,227 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $14,792,692 | 511,504 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $17,626,388 | 545,371 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $15,939,495 | 546,622 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $16,458,588 | 617,120 | Shares | Defined | 2021-11-18 | |
| 2021-06-30 | $18,760,160 | 609,294 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $17,191,827 | 656,678 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $16,511,272 | 656,251 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $13,777,466 | 661,107 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $16,297,700 | 686,219 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $12,471,133 | 693,226 | Shares | Defined | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||